Nikolaos Samaras

Off-label use of hormones as an antiaging strategy: a review

Given demographic evolution of the population in modern societies, one of the most important health care needs is successful aging with less frailty and dependency. During the last 20 years, a multitude of anti-aging practices have appeared worldwide, aiming at retarding or even stopping and reversing the effects of aging on the human body. One of the cornerstones of anti-aging is hormone replacement. At present, women live one third of their lives in a state of sex-hormone deficiency. Men are also subject to age-related testosterone decline, but andropause remains frequently under-diagnosed and under-treated. Due to the decline of hormone production from gonads in both sexes, the importance of dehydroepiandrosterone (DHEA) in steroid hormone production increases with age. However, DHEA levels also decrease with age. Also, growth hormone age-associated decrease may be so important that insulin growth factor-1 levels found in elderly individuals are sometimes as low as those encountered in adult patients with established deficiency. Skin aging as well as decreases in lean body mass, bone mineral density, sexual desire and erectile function, intellectual activity and mood have all been related to this decrease of hormone production with age. Great disparities exist between recommendations from scientific societies and actual use of hormone supplements in aging and elderly patients. In this article, we review actual data on the effects of age related hormone decline on the aging process and age-related diseases such as sarcopenia and falls, osteoporosis, cognitive decline, mood disorders, cardiovascular health and sexual activity. We also provide information on the efficiency and safety of hormone replacement protocols in aging patients. Finally, we argue on future perspectives of such protocols as part of everyday practice.

Transcatheter aortic valve implantation in nonagenarians: Effective and safe

BACKGROUND The number of nonagenarians is rising dramatically. These patients often develop severe aortic stenosis for which transcatheter aortic valve implantation (TAVI) is an attractive option. The aim of this study was to analyze the outcome of TAVI performed in a cohort of nonagenarian patients. METHODS Between August 2008 and November 2012, 23 consecutive patients in their 90th year of age or older underwent TAVI in our institution after having been assessed by the local heart team. Data concerning baseline characteristics, procedural details and outcome were prospectively entered into a dedicated database. Transthoracic echocardiography and clinical follow-up were performed pre-procedure, at discharge, at 6 and 12 months and then annually post TAVI. RESULTS Patients were male in 52% with a mean age of 90.3 ± 2.3 years. Mean logistic EuroSCORE and STS score were 26.6 ± 14.5% and 8.7 ± 2.9%, respectively. Transcatheter heart valve (THV) could be implanted in all but one patient. Mortality at 30 days was 8.7% overall and 4.8% for transfemoral approach. At 30 days the rate of stroke was 4.3%, paravalvular leak grade ≥ 2 was 8.7%, life-threatening bleeding was 13.0% and pacemaker implantation was 13%. Device success was 73.9%. The rate of all-cause mortality increased to 27.3% at one-year follow-up and 42.8% at a median follow-up of 417 days. CONCLUSIONS TAVI is safe and effective even in a selected population of nonagenarians. Consequently, these patients should not be refused such a procedure based only on their age. Multi-disciplinary assessment is essential in order to properly select candidates.

Effects of widely used drugs on micronutrients: a story rarely told.

Vitamins and trace elements are essential to the body, however, deficiencies are frequently observed in the general population. Diet is mostly responsible for these deficiencies but drugs also may play a significant role by influencing their metabolism. These effects are rarely assessed in clinical practice, in part because of limited data available in the literature. Drug-induced micronutrient depletions, however, may be the origin of otherwise unexplained symptoms that might sometimes influence medication compliance. We present various examples of widely prescribed drugs that can precipitate micronutrient deficiencies. This review aims at sensitizing physicians on drug-micronutrient interactions. High-risk population groups also are presented and supplementation protocols are suggested.

Testosterone Replacement Therapy in Reversing “Andropause”: What Is the Proof-of-Principle?

Abstract Testosterone replacement therapy is often equated with the macho male physique and virility and is viewed by some as an antiaging tonic. The growth in testosterones reputation and its increased use by men of all ages has seemed to outpace the scientific evidences. This review will aim to examine the uncertainty regarding the nature and the clinical importance of the age-related reduction in the testosterone levels. Considerations will be given both to clinical symptoms, biochemical and clinical diagnostic criteria, and to the risk-to-benefit ratio of reversing late-onset hypogonadism in aging and older men.

Pulmonary rehabilitation: the reference therapy for undernourished patients with chronic obstructive pulmonary disease.

Chronic obstructive pulmonary disease (COPD) combines the deleterious effects of chronic hypoxia, chronic inflammation, insulin-resistance, increased energy expenditure, muscle wasting, and exercise deconditioning. As for other chronic disorders, loss of fat-free mass decreased survival. The preservation of muscle mass and function, through the protection of the mitochondrial oxidative metabolism, is an important challenge in the management of COPD patients. As the prevalence of the disease is increasing and the medical advances make COPD patients live longer, the prevalence of COPD-associated nutritional disorders is expected to increase in future decades. Androgenopenia is observed in 40% of COPD patients. Due to the stimulating effects of androgens on muscle anabolism, androgenopenia favors loss of muscle mass. Studies have shown that androgen substitution could improve muscle mass in COPD patients, but alone, was insufficient to improve lung function. Two multicentric randomized clinical trials have shown that the association of androgen therapy with physical exercise and oral nutritional supplements containing omega-3 polyinsaturated fatty acids, during at least three months, is associated with an improved clinical outcome and survival. These approaches are optimized in the field of pulmonary rehabilitation which is the reference therapy of COPD-associated undernutrition.

Influenza vaccination in the face of immune exhaustion: is herd immunity effective for protecting the elderly?

At the start of the 21st century, seasonal influenza virus infection is still a major public health concern across the world. The recent body of evidence confirms that trivalent inactivated influenza vaccines (TIVs) are not optimal within the population who account for approximately 90% of all influenza-related death: elderly and chronically ill individuals regardless of age. With the ever increasing aging of the world population and the recent fears of any pandemic influenza rife, great efforts and resources have been dedicated to developing more immunogenic vaccines and strategies for enhancing protection in these higher-risk groups. This paper describes the mechanisms that shape immune response at the extreme ages of life and how they have been taken into account to design more effective immunization strategies for these vulnerable populations. Furthermore, consideration will be given to how herd immunity may provide an effective strategy in preventing the burden of seasonal influenza infection within the aged population.

A Rare Case of Adrenal Insufficiency Induced by Inhaled Corticosteroids

1. Christensen PB, Jensen TS, Tsiropoulous I et al. Incidence and prevalence of myasthenia gravis in western Denmark: 1975–1989. Neurology 1993;43:1779–1783. 2. Phillips LH, Torner JC. Epidemiology evidence for a changing natural history of myasthenia gravis. Neurology 1996;47:1233–1238. 3. Schon F, Drayson M, Thompson RA. Myasthenia gravis and elderly people. Age Aging 1996;25:56–58. 4. Aragon es JM, Bol ıbar I, Bonfill X et al. Myasthenia gravis: A higher than expected incidence in the elderly. Neurology 2003;60:1024–1026. 5. Vincent A, Clover L, Buckley C et al. UK Myasthenia Gravis Survey. Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry 2003;74:1105–1108. 6. Lawrence H, Phillips LH. The epidemiology of myasthenia gravis. Semin Neurol 2004;1:17–20. 7. Matsui N, Nakane S, Nakagawa Y et al. Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan. J Neurol Neurosurg Psychiatry 2009;80:1168–1171.

Comparison of the interobserver variability of 2 different methods of dietary assessment in a geriatric ward: a pilot study

BACKGROUND Protein-energy malnutrition is highly prevalent in aged populations. Associated clinical, economic, and social burden is important. A valid screening method that would be robust and precise, but also easy, simple, and rapid to apply, is essential for adequate therapeutic management. OBJECTIVES To compare the interobserver variability of 2 methods measuring food intake: semiquantitative visual estimations made by nurses versus calorie measurements performed by dieticians on the basis of standardized color digital photographs of servings before and after consumption. DESIGN Observational monocentric pilot study. SETTING/PARTICIPANTS A geriatric ward. The meals were randomly chosen from the meal tray. The choice was anonymous with respect to the patients who consumed them. MEASUREMENTS The test method consisted of the estimation of calorie consumption by dieticians on the basis of standardized color digital photographs of servings before and after consumption. The reference method was based on direct visual estimations of the meals by nurses. Food intake was expressed in the form of a percentage of the serving consumed and calorie intake was then calculated by a dietician based on these percentages. The methods were applied with no previous training of the observers. Analysis of variance was performed to compare their interobserver variability. RESULTS Of 15 meals consumed and initially examined, 6 were assessed with each method. Servings not consumed at all (0% consumption) or entirely consumed by the patient (100% consumption) were not included in the analysis so as to avoid systematic error. The digital photography method showed higher interobserver variability in calorie intake estimations. The difference between the compared methods was statistically significant (P < .03). CONCLUSIONS Calorie intake measures for geriatric patients are more concordant when estimated in a semiquantitative way. Digital photography for food intake estimation without previous specific training of dieticians should not be considered as a reference method in geriatric settings, as it shows no advantages in terms of interobserver variability.

An unusual case of cholecystitis and liver abscesses in an older adult

1. Wilmore LJ, Wheless JW, Pellock JM. Adverse effects of anti-epileptic drugs. In: Pellock JM, Dodson WE, Bourgeois BF. Pediatric Epilepsy. New York: Demos. 2001, pp 343–355. 2. Cereghino JJ, Biton V, Abon-khalil B et al. Levetiracetam for partial seizures. Neurology 2000;55:236–242. 3. Kossoff EH, Bergey GK, Freeman JM et al. Levetiracetam psychosis in children as epilepsy. Epilepsia 2001;42:1611–1613. 4. Youroukos S, Lazopoulou D, Michelakou D et al. Acute psychosis associated with levetiracetam. Epileptic Disord 2003;2:117–119. 5. Mula M, Trimble MR, Yuen A et al. Psychiatric adverse events during levetiracetam therapy. Neurology 2003;61:704–706. 6. Mula M, Trimble MR, Sander JW. Are Psychiatric adverse events of antiepileptic drugs unique entity? A study on topiramate and levetiracetam. Epilepsia 2007;48:2322–2326. 7. Foley KT, Bugg KS. Separate episodes of delirium associated with levetiracetam and amiodarone treatment in an elderly woman. Am J Geriatr Pharmacother 2010;8:170–174. 8. VandeGriend JP, Linnebur SA, Bainbridge JL. Probable Levetiracetam associated depression in the elderly: Two case reports. Am J Geriatr Pharmacother 2009;7:281–284. 9. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–245.

Cauliflower Bowel: A Tumor-Induced Mesenteric Retraction

CLINICAL PRESENTATION A 60-year-old female patient presented with epigastric pain, lower dysphagia, postprandial vomiting and significant weight loss. Upper endoscopy revealed an obstructive lesion of the esophagogastric junction, and biopsy analysis showed a squamous cell carcinoma of low differentiation. Endoscopic ultrasonography, computer tomography and positron emission tomography-computer tomography suggested a T2N1M0 stage. Initial treatment included neoadjuvant chemotherapy with Cisplatin and Docetaxel, followed by a simultaneous chemotherapy and radiotherapy. Four months later, she underwent a subtotal esophagogastrectomy. Follow-up at 2 months showed tumor progression with multiple hepatic metastasis, peritoneal carcinomatosis, and ascites. A “cauliflower” image of the small intestine at abdominal computer tomography (Figure 1) suggested mesenteric retraction. Mesenteric retraction may be the result of autoimmune diseases, abdominal trauma or surgery, mesenteric ischemia or infection and malignancies. Evidently, our case was associated with the peritoneal carcinomatosis. The patient’s general condition degraded rapidly, and she was referred for palliative care, where she passed away 2 weeks later.